AU4810600A - Method of inhibiting leukocyte adhesion to fibrinogen - Google Patents
Method of inhibiting leukocyte adhesion to fibrinogenInfo
- Publication number
- AU4810600A AU4810600A AU48106/00A AU4810600A AU4810600A AU 4810600 A AU4810600 A AU 4810600A AU 48106/00 A AU48106/00 A AU 48106/00A AU 4810600 A AU4810600 A AU 4810600A AU 4810600 A AU4810600 A AU 4810600A
- Authority
- AU
- Australia
- Prior art keywords
- fibrinogen
- leukocyte adhesion
- inhibiting leukocyte
- inhibiting
- adhesion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000008946 Fibrinogen Human genes 0.000 title 1
- 108010049003 Fibrinogen Proteins 0.000 title 1
- 229940012952 fibrinogen Drugs 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000023404 leukocyte cell-cell adhesion Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13240499P | 1999-04-28 | 1999-04-28 | |
| US60132404 | 1999-04-28 | ||
| PCT/US2000/011685 WO2000064925A1 (en) | 1999-04-28 | 2000-04-28 | Method of inhibiting leukocyte adhesion to fibrinogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4810600A true AU4810600A (en) | 2000-11-10 |
Family
ID=22453897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU48106/00A Abandoned AU4810600A (en) | 1999-04-28 | 2000-04-28 | Method of inhibiting leukocyte adhesion to fibrinogen |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1173466A4 (en) |
| AU (1) | AU4810600A (en) |
| CA (1) | CA2367830A1 (en) |
| WO (1) | WO2000064925A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1377314E (en) * | 2001-01-26 | 2012-01-02 | Inhibitex Inc | Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| KR101661946B1 (en) | 2007-08-31 | 2016-10-05 | 유니버시티 오브 시카고 | Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| AU2012216332B8 (en) * | 2008-01-31 | 2015-04-30 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Treatment of microbial infections |
| CA2713241C (en) * | 2008-01-31 | 2022-10-04 | Timothy Foster | Treatment of microbial infections |
| SG174968A1 (en) | 2009-04-03 | 2011-11-28 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
| US9353160B2 (en) | 2009-07-16 | 2016-05-31 | Glaxosmithkline Biologicals S.A. | Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof |
| SG186290A1 (en) | 2010-07-02 | 2013-01-30 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| KR20220025724A (en) | 2019-05-14 | 2022-03-03 | 더 유니버서티 오브 시카고 | Methods and compositions comprising variants of Staphylococcus protein A |
| CN114929750B (en) | 2019-09-13 | 2024-11-22 | 芝加哥大学 | Methods and compositions for treating staphylococcal infections |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008341A (en) * | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
-
2000
- 2000-04-28 CA CA002367830A patent/CA2367830A1/en not_active Abandoned
- 2000-04-28 WO PCT/US2000/011685 patent/WO2000064925A1/en not_active Ceased
- 2000-04-28 EP EP00930252A patent/EP1173466A4/en not_active Withdrawn
- 2000-04-28 AU AU48106/00A patent/AU4810600A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000064925A1 (en) | 2000-11-02 |
| WO2000064925A9 (en) | 2002-06-27 |
| EP1173466A1 (en) | 2002-01-23 |
| CA2367830A1 (en) | 2000-11-02 |
| EP1173466A4 (en) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4515597A (en) | Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists | |
| AU4269896A (en) | Fibronectin adhesion inhibitors | |
| AU6762400A (en) | Inhibitors of factor xa | |
| AU5283800A (en) | Inhibitors of factor xa | |
| AU5158100A (en) | Inhibitors of factor xa | |
| AU5283900A (en) | Inhibitors of factor xa | |
| AU3857300A (en) | Inhibitors of factor xa | |
| AU2623900A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| AU5283600A (en) | Inhibitors of factor xa | |
| AU4494396A (en) | Proline derivatives useful as inhibitors of human leukocyte elastase | |
| AU4810600A (en) | Method of inhibiting leukocyte adhesion to fibrinogen | |
| HRP20010527B1 (en) | Derivatives of monosaccharides as cell adhesion inhibitors | |
| AU2217300A (en) | Method of improving adhesion to galvanized surfaces | |
| AU2001268701A1 (en) | Methods of enhancing adhesion | |
| AU1183101A (en) | Method relating to anodic bonding | |
| AU2001293011A1 (en) | Method for adhesion of polymers to metal-coated substrates | |
| AU2001282938A1 (en) | Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4 | |
| AU2623800A (en) | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| AU8005100A (en) | Inhibitors of neuraminidases | |
| AU3348700A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| AU3899200A (en) | Treatment to lower platelet adhesiveness | |
| AU7711800A (en) | Novel uses of 2-bromopalmitate | |
| AU4021700A (en) | Methods of use of beta1-integrin inhibitors | |
| AUPP751198A0 (en) | Purification of A1-proteinase inhibitor | |
| AUPP521298A0 (en) | Purification of fibrinogen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |